<DOC>
	<DOCNO>NCT02266342</DOCNO>
	<brief_summary>This French Registry mandate French National Health Authority assess long-term ( 5-years ) safety GORE® TAG® Thoracic Endoprosthesis treat disease thoracic aorta .</brief_summary>
	<brief_title>GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry</brief_title>
	<detailed_description>Endovascular therapy treat thoracic disease seem provide plausible benefit compare surgery term operative mortality severe morbidity . The French National Health Authority ( HAS ) require 5-year follow-up part renewal reimbursement endoprostheses order collect long-term follow-up data real-life condition use .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Rupture</mesh_term>
	<mesh_term>Aortic Diseases</mesh_term>
	<mesh_term>Aortic Aneurysm , Thoracic</mesh_term>
	<criteria>Patient GORE® TAG® Conformable GORE® TAG® Thoracic Endoprosthesis implant ( successfully ) treatment disease descend thoracic aorta . Patient previously consent collection process personal medical data . Patient old 18 year time treatment . Patients already receive treatment thoracic endoprosthesis GORE® TAG® Conformable GORE® TAG® Thoracic Endoprosthesis 'revision ' reintervention require . Patients whose clinical followup possible ( i.e . patient return control visit live abroad ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>